Cedars-Sinai 18th Annual Women and Ischemic Heart Disease Symposium 2024 (Videos + PDFs)

Advanced Women’s Cardiovascular Health, Prevention, and Ischemic Heart Disease Update

The Cedars-Sinai 18th Annual Women and Ischemic Heart Disease Symposium 2024 delivers a comprehensive review of sex-specific cardiovascular disease, preventive cardiology, ischemic heart disease, coronary microvascular dysfunction, obesity management, hormonal influences, and emerging cardiovascular risk factors unique to women.

Led by nationally recognized experts from Cedars-Sinai Medical Center, this symposium focuses on the latest evidence-based approaches to prevention, diagnosis, and treatment of cardiovascular disease in women. Through expert lectures, clinical case discussions, and practical guideline updates, participants gain the knowledge needed to improve outcomes in female patients across all stages of life.

Format: 18 Videos + 9 PDFs
File Size: 4.37 GB
Date: April 12, 2024
Location: Los Angeles, California
Specialty: Women’s Cardiovascular Health | Preventive Cardiology | Ischemic Heart Disease

Course Overview

Cardiovascular disease remains the leading cause of death among women worldwide. However, sex-specific risk factors, hormonal influences, pregnancy-related complications, and unique disease presentations often contribute to delayed diagnosis and undertreatment.

The 18th Annual Women and Ischemic Heart Disease Symposium explores modern strategies for identifying cardiovascular risk, preventing disease progression, recognizing atypical presentations, and optimizing treatment for women with ischemic heart disease and related cardiovascular disorders.

Participants learn how emerging therapies, precision medicine approaches, and gender-focused care models are reshaping women’s cardiovascular health.

Target Audience

This program is designed for:

Physicians

• Cardiologists

• Preventive Cardiologists

• Internal Medicine Physicians

• Family Medicine Physicians

• Obstetricians & Gynecologists

• Endocrinologists

• Emergency Medicine Physicians

Advanced Practice Providers

• Nurse Practitioners

• Physician Assistants

Nursing Professionals

• Cardiovascular Nurses

• Women’s Health Nurses

Healthcare Professionals

• Clinicians Interested in Women’s Cardiovascular Health

• Preventive Medicine Specialists

Learning Objectives

Upon completion of this activity, participants should be able to:

• Identify social determinants affecting women’s cardiovascular health

• Apply evidence-based screening strategies for heart disease in women

• Optimize prevention and management of obesity and diabetes in women

• Recognize sex-specific presentations of ischemic heart disease

• Diagnose and manage coronary microvascular dysfunction

• Understand hormonal influences on cardiovascular risk

• Evaluate heart failure in women using modern diagnostic approaches

• Address disparities in cardiovascular care delivery

Women’s Cardiovascular Health

Sex-Specific Cardiovascular Risk Factors

Topics Covered

• Pregnancy-Related Cardiovascular Risk

• Hypertensive Disorders of Pregnancy

• Gestational Diabetes

• Menopause

• Autoimmune Disease

• Polycystic Ovary Syndrome (PCOS)

Social Determinants of Health

Areas Covered

• Access to Healthcare

• Health Equity

• Socioeconomic Factors

• Lifestyle Influences

• Preventive Care Barriers

Life’s Essential 8 and Prevention

Comprehensive Cardiovascular Prevention

Topics Include

• Blood Pressure Control

• Cholesterol Management

• Blood Sugar Optimization

• Physical Activity

• Healthy Nutrition

• Sleep Health

• Tobacco Avoidance

• Weight Management

Risk Assessment in Women

Areas Covered

• Early Detection Strategies

• Cardiovascular Risk Prediction

• Primary Prevention

• Secondary Prevention

Cholesterol Management

Modern Lipid Therapy

Topics Covered

• LDL Cholesterol Targets

• Statin Therapy

• PCSK9 Inhibitors

• Novel Lipid-Lowering Agents

• High-Risk Female Patients

Obesity and Cardiometabolic Disease

GLP-1 Receptor Agonists

Topics Include

• Weight Reduction Strategies

• Cardiovascular Benefits

• Diabetes Management

• Emerging Clinical Evidence

• Patient Selection

Women’s Obesity Management

Areas Covered

• Lifestyle Intervention

• Pharmacotherapy

• Long-Term Cardiovascular Risk Reduction

Hormones and Cardiovascular Disease

Hormonal Influences on Heart Health

Topics Covered

• Menopause and Cardiovascular Risk

• Hormone Replacement Therapy

• Estrogen Effects

• Reproductive Health Considerations

• Individualized Treatment Approaches

Heart Failure in Women

Recognition and Diagnosis

Topics Include

• HFpEF in Women

• Sex Differences in Presentation

• Diagnostic Challenges

• Biomarkers

• Imaging Approaches

Management Strategies

Areas Covered

• Guideline-Directed Medical Therapy

• Emerging Treatments

• Multidisciplinary Care

Coronary Microvascular Disease

Microvascular Angina and INOCA

Topics Covered

• Ischemia With Non-Obstructive Coronary Arteries (INOCA)

• Coronary Microvascular Dysfunction

• Diagnostic Testing

• Coronary Reactivity Assessment

• Treatment Strategies

Clinical Importance

Areas Covered

• Chest Pain Evaluation

• Women’s Ischemic Syndromes

• Long-Term Prognosis

Postural Orthostatic Tachycardia Syndrome (POTS)

Diagnosis and Management

Topics Include

• Clinical Recognition

• Autonomic Dysfunction

• Diagnostic Criteria

• Medical Management

• Lifestyle Modification

Sex Differences in Cardiovascular Medicine

Gender-Specific Considerations

Topics Covered

• Symptom Presentation

• Diagnostic Bias

• Treatment Adherence

• Remote Monitoring

• Outcome Differences

Case-Based Learning

Participants review:

• Young Women With Cardiovascular Risk

• Coronary Microvascular Disease Cases

• Women With Heart Failure

• Obesity and Diabetes Management

• POTS Evaluation

• Hormone-Related Cardiovascular Conditions

• Preventive Cardiology Cases

Educational Highlights

Cedars-Sinai Expert Faculty

Learn from nationally recognized leaders in women’s cardiovascular medicine and preventive cardiology.

Evidence-Based Curriculum

Incorporates the latest guidelines, clinical trials, and emerging therapies.

Women’s Health Focus

Addresses cardiovascular conditions uniquely affecting women.

Practical Clinical Application

Provides actionable strategies for immediate implementation in clinical practice.

Why This Course Stands Out

✔ Comprehensive Women’s Cardiovascular Health Review

✔ Ischemic Heart Disease in Women

✔ Coronary Microvascular Dysfunction Education

✔ Prevention and Risk Assessment Strategies

✔ GLP-1 Agonist Cardiovascular Applications

✔ Hormonal and Menopause-Related Cardiology Updates

✔ Heart Failure in Women

✔ POTS Diagnosis and Management

✔ Social Determinants of Health Discussion

✔ Sex-Specific Cardiovascular Medicine

✔ Evidence-Based Clinical Guidance

✔ Expert Cedars-Sinai Faculty

Who Should Take This Course?

Ideal for:

• Cardiologists

• Obstetricians & Gynecologists

• Internal Medicine Physicians

• Family Medicine Physicians

• Endocrinologists

• Preventive Medicine Specialists

• Nurse Practitioners

• Physician Assistants

• Women’s Health Clinicians

Clinical & Educational Value

The Cedars-Sinai 18th Annual Women and Ischemic Heart Disease Symposium 2024 provides a modern, evidence-based review of cardiovascular disease in women, emphasizing prevention, ischemic heart disease, obesity, diabetes, hormonal influences, heart failure, and coronary microvascular dysfunction. Participants gain practical tools to improve diagnosis, treatment, and long-term cardiovascular outcomes for female patients.

Topics:

• Agenda.pdf
• CASES- Postural Orthostatic Tachycardia Syndrome Q&A.mp4
• CASES- Postural Orthostatic Tachycardia Syndrome.mp4
• CASES- Postural Orthostatic Tachycardia Syndrome.pdf
• Coronary Microvascular Disease- Access to Diagnosis Q&A.mp4
• Coronary Microvascular Disease- Access to Diagnosis.mp4
• Coronary Microvascular Disease- Access to Diagnosis.pdf
• Debate- GLP RA should be first line therapy for Treatment of Obesity 2.mp4
• Debate- GLP RA should be first line therapy for Treatment of Obesity Q&A 2.mp4
• Debate- GLP RA should be first line therapy for Treatment of Obesity.mp4
• Debate- GLP RA should be first line therapy for Treatment of Obesity.pdf
• Debate- Hormone Therapy and Cardiovascular Disease Q&A.mp4
• Debate- Hormone Therapy and Cardiovascular Disease.mp4
• Debate- Hormone Therapy and Cardiovascular Disease.pdf
• Debate- Hormone Therapy Why When We Should Say YES.mp4
• Dispelling the Myths- Women’s Cardiovascular Health Q&A.mp4
• Dispelling the Myths- Women’s Cardiovascular Health.mp4
• Dispelling the Myths- Women’s Cardiovascular Health.pdf
• Keynote Lecture- Sex differences in HF – detection, diagnosis, and management Q&A.mp4
• Keynote Lecture- Sex differences in HF – detection, diagnosis, and management.mp4
• Keynote Lecture- Sex differences in HF – detection, diagnosis, and management.pdf
• Prevention – Life’s Essential 8 Q&A.mp4
• Prevention – Life’s Essential 8.mp4
• Prevention – Life’s Essential 8.pdf
• Somethings Old, Somethings New- Cholesterol Management in 2024 Q&A.mp4
• Somethings Old, Somethings New- Cholesterol Management in 2024.mp4
• Somethings Old, Somethings New- Cholesterol Management in 2024.pdf